Related references
Note: Only part of the references are listed.SCORING SYSTEMS TO ESTIMATE INTRACEREBRAL CONTROL AND SURVIVAL RATES OF PATIENTS IRRADIATED FOR BRAIN METASTASES
Dirk Rades et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
DO PATIENTS RECEIVING WHOLE-BRAIN RADIOTHERAPY FOR BRAIN METASTASES FROM RENAL CELL CARCINOMA BENEFIT FROM ESCALATION OF THE RADIATION DOSE?
Dirk Rades et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
DOSE ESCALATION OF WHOLE-BRAIN RADIOTHERAPY FOR BRAIN METASTASES FROM MELANOMA
Dirk Rades et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Dose Escalation in Patients Receiving Whole-Brain Radiotherapy for Brain Metastases from Colorectal Cancer
Christine Heisterkamp et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis
Dirk Rades et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases
Dirk Rades et al.
CANCER (2007)
Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases
Dirk Rades et al.
CANCER (2007)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
MP Mehta et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase II Randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases
D Antonadou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1
G Robinet et al.
ANNALS OF ONCOLOGY (2001)
Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
PE Postmus et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy
A Trotti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
